Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder: Comparison Between Patients With and Without OBesity

NCT07121621 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT07121621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07121621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder: Comparison Between Patients With and Without OBesity
Lead sponsor
University Hospital, Tours
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
September 2, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder (adhd), methylphenidate, obesity & overweight, obesity (body mass index >30 kg/m2)